Cognitive performance following fluoxetine treatment in depressed patients post myocardial infarction

J.J.M.H. Strik*, A. Honig, E.L. Klinkenberg, J. Dijkstra, J. Jolles

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)


Background: As depression is a considerable risk factor for an unfa- University of Maastricht, The Netherlands vourable course of myocardial infarction (MI), antidepressant treatment of post-MI depression and, inherent to MI status, polypharmacy has become an important issue. Objective: The present study is the first to evaluate cognitive side effects of fluoxetine, as part of a placebo-controlled double-blind trial, in patients with post-first MI depression. Methods: Cognitive performance of 54 depressed patients post first-MI treated with fluoxetine or placebo was compared. Cognitive performance was tested before and after 9 weeks of treatment using the Visual Verbal Learning Test, Concept Shifting Task, Stroop Colour-Word Test and Letter-Digit-Substitution Test. Results: The median number of cardiovascular drugs taken by MI patients was 4.9. There were no differences between the fluoxetine and the placebo group on cognitive performance. Conclusion: In sum, there were no negative side effects of fluoxetine compared with placebo on cognition in depressed MI patients, simultaneously treated with cardiac drugs.
Original languageEnglish
Pages (from-to)1-2007
JournalActa Neuropsychiatrica
Publication statusPublished - 1 Jan 2006


Dive into the research topics of 'Cognitive performance following fluoxetine treatment in depressed patients post myocardial infarction'. Together they form a unique fingerprint.

Cite this